| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 6.689 | 7.497 | 12.604 | 16.539 | 4.152 | 0 | 1.986 | 5.327 |
| Total Income - EUR | 0 | 0 | 6.788 | 7.723 | 13.067 | 16.927 | 4.415 | 1.930 | 1.656 | 5.329 |
| Total Expenses - EUR | 1.237 | 1.483 | 2.539 | 1.986 | 2.375 | 1.159 | 2.347 | 1.727 | 1.418 | 2.815 |
| Gross Profit/Loss - EUR | -1.237 | -1.483 | 4.249 | 5.736 | 10.692 | 15.769 | 2.068 | 203 | 238 | 2.513 |
| Net Profit/Loss - EUR | -1.237 | -1.483 | 4.045 | 5.509 | 10.303 | 15.277 | 1.938 | 197 | 200 | 2.111 |
| Employees | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neurocord Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 612 | 533 | 457 | 382 | 311 | 278 | 199 | 239 | 277 |
| Current Assets | 254 | 72 | 6.975 | 14.669 | 26.234 | 27.492 | 17.098 | 16.489 | 17.012 | 21.277 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.872 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 4.145 | 0 | 4.435 | 151 | 146 | 2.132 | 475 |
| Cash | 254 | 72 | 6.975 | 10.524 | 26.234 | 23.057 | 16.947 | 14.471 | 14.880 | 20.802 |
| Shareholders Funds | -3.437 | -4.885 | -755 | 4.768 | 10.356 | 15.329 | 15.395 | 15.640 | 15.792 | 2.162 |
| Social Capital | 45 | 45 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 3.690 | 5.569 | 8.263 | 10.358 | 16.280 | 12.474 | 1.981 | 1.075 | 1.486 | 19.424 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Neurocord Medical Srl